Materialise Q3 Earnings Call Highlights

Materialise NASDAQ: MTLS reported third-quarter 2026 revenue growth led by its medical business, while higher research and development spending and one-time costs weighed on operating profitability. The company reaffirmed its full-year revenue and adjusted EBIT guidance.

MarketBeat • Oct 28, 2026

Materialise NV (MTLS) Q3 2026 Earnings Call Transcript

Materialise NV ( MTLS ) Q3 2026 Earnings Call October 28, 2026 8:30 AM EDT Company Participants Brigitte de Vet-Veithen - Chief Executive Officer Koen Berges - Chief Financial Officer Conference Call Participants Jody Burfening Troy Jensen - Cantor Fitzgerald & Co., Research Division Presentation Operator Thank you for standing by, and welcome to the Third Quarter 2026 Materialise NV Financial Results Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded.

Seeking Alpha • Oct 28, 2026

Materialise Reports Third Quarter 2026 Results

LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (Euronext & NASDAQ:MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, today announced its financial results for the third quarter ended September 30, 2026. Highlights – Third Quarter 2026 Total revenue increased by 2.1% to 67,670 kEUR for the third quarter of 2026 compared to 66,259 kEUR for the corresponding 2025 period. Excluding last year's revenue for the recen.

Business Wire • Oct 28, 2026

Materialise NV to Report Third Quarter 2026 Earnings on Wednesday, October 28, 2026

LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (Euronext & NASDAQ: MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, today announced that it will release financial results for the third quarter ended September 30, 2026 on Wednesday, October 28, 2026 at 2:00 a.m. ET/7:00 a.m. CET. Senior management will hold a conference call to discuss the third quarter 2026 financial results on Wednesday, October 28, 2026 at.

Business Wire • Oct 16, 2026

Materialise: A High-Margin Medical Business Hiding In Plain Sight

Materialise's Medical continues to deliver double-digit growth and strong margins and is increasingly underpinning the company's value. The Manufacturing segment is recovering, with aerospace strength offsetting weak prototyping demand and creating significant potential for margin expansion. Software is now an uncertainty, as recurring revenue growth has stalled despite Materialise's transition toward subscriptions and the introduction of new CO-AM products.

Seeking Alpha • Aug 31, 2026

Materialise Q2 Earnings Call Highlights

Materialise NASDAQ: MTLS reported second-quarter revenue growth of more than 8% year over year to €70.1 million, driven by double-digit expansion in its Medical segment and continued improvement in profitability. The company raised its full-year adjusted EBIT outlook while maintaining its revenue guidance, despite the anticipated revenue effect of divesting its RapidFit and Eyewear businesses.

MarketBeat • Aug 27, 2026

Materialise NV (MTLS) Q2 2026 Earnings Call Transcript

Materialise NV (MTLS) Q2 2026 Earnings Call Transcript

Seeking Alpha • Aug 27, 2026

Materialise Reports Second Quarter and Half-Year 2026 Results

LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (Euronext & NASDAQ:MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, today announced its financial results for the second quarter and the six months ended June 30, 2026. Highlights – Second Quarter 2026 Total revenue increased by 8.1% to 70,073 kEUR for the second quarter of 2026 compared to 64,831 kEUR for the corresponding 2025 period. Adjusted EBITDA increased.

Business Wire • Aug 27, 2026

Materialise NV to Report Second Quarter and Half-Year 2026 Earnings on Thursday, August 27, 2026

LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (Euronext & NASDAQ: MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, today announced that it will release financial results for the second quarter and the six months ended June 30, 2026 on Thursday, August 27, 2026 at 1:00 a.m. ET/7:00 a.m. CET. Senior management will hold a conference call to discuss the second quarter and the six months ended June 30, 2026 fina.

Business Wire • Aug 13, 2026

Materialise: Maturing Transition Should Lead To Stronger Performance Going Forward

While Materialise's Q1 results were soft, its Medical segment appears to be stabilizing and the software business model transition is nearing completion. Cost discipline and a return to growth should see margins start to consistently move higher, assuming that the macro environment remains stable. Despite the stock moving higher in recent months, a material improvement in performance still isn't priced into the stock.

Seeking Alpha • Jul 22, 2026